Ranbaxy Laboratories is planning to set up overseas facilities as part of efforts to enhance its overall business.
The company will be setting up two new manufacturing facilities in Nigeria and Malaysia. However, the company did not disclose financial details about the plants.The Nigeria facility will be for upgrading liquid manufacturing capacity to produce around 14 million units per annum as well as to have capacity for manufacturing up to 100 million units of tablets and capsules per annum. It is expected to be ready by December 2012 and production is likely to start from first quarter of 2013. The Malaysia facility with a capacity of 2.5 billion doses per annum is slated to be ready in 2014.
Malaysia, South Africa, Nigeria, Egypt and Morocco are among the strategic markets identified by the company.
Also see:
Ranbaxy opens new manufacturing facility in Morocco (12-March-12)